The epidemiology of meningococcal disease and the impact of vaccines. - Wikidata - awgldk - TriplyDB

The epidemiology of meningococcal disease and the impact of vaccines.

The epidemiology of meningococcal disease and the impact of vaccines.

http://www.wikidata.org/entity/Q37706585

about

Meningococcal disease in childhood: epidemiology, clinical features and prevention Emerging experience with meningococcal serogroup B protein vaccines.Polysaccharide-specific B cell responses to vaccination in humans An epidemiological review of changes in meningococcal biology during the last 100 years Meningococcal serogroup B disease in Turkey: a guess or reality?A decade of invasive meningococcal disease surveillance in Poland.Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country.Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.Applying the bacterial meningitis score in children with cerebrospinal fluid pleocytosis: a single center's experience.The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.A Survey of Serum Bactericidal Antibodies against Neisseria meningitidis Serogroups A, C, W and Y in Adolescents and Adults in the Republic of Korea.Meningococcal Disease in Korea: an Epidemiologic Study of the Underestimated Infectious Disease Routinely vaccinating adolescents against meningococcus: targeting transmission & disease A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years.Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis.The changing epidemiology of meningococcal disease in North America 1945-2010.Impact of vaccination on meningococcal epidemiology Immunogenicity of a Meningococcal B Vaccine during a University Outbreak.Meningococcal polysaccharide A O-acetylation levels do not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine: results from a randomized, controlled phase III study of healthy adults aged 18 to 25 years.A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine.Paediatric meningococcaemia in northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination.Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulence.Increase of meningococcal serogroup Y cases in Europe: a reason for concern?Designing a new antifungal glycoconjugate vaccine.Meningococcal groups C and Y and haemophilus B tetanus toxoid conjugate vaccine (HibMenCY-TT; MenHibrix(®)): a review.The history of pneumococcal conjugate vaccine development: dose selection.Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives.Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience.Aseptic meningitis caused by Leptospira spp diagnosed by polymerase chain reaction.Recognizing the Importance of Vaccine Confidence.Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States.Impact of Meningococcal C Conjugate Vaccination Programs with and without catch-up campaigns in adolescents: lessons learned from Bahia, Brazil.4CMenB vaccine effectiveness: reasons for optimism.Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy.Challenges and opportunities for Meningococcal vaccination in the developing world.

P2860

Q26770704-E104B8C2-94B3-43A6-8CB9-99C37380AEA8 Q30234958-0ACAEF91-3653-419D-BEB9-8347BED3A2B3 Q33577958-7CD2C27F-3B20-469F-9177-53E365B0E0CD Q33850814-570D7801-2224-4640-8A87-3903D5A01494 Q34290937-4400E849-78EA-4C6A-BB0D-8427EABE0E16 Q34972731-59D6AE96-E907-4A2A-A183-07C6119498CF Q35198778-5E6B9D9E-C6DF-431C-9415-F8C5CE9D4785 Q35683382-A697519E-70D0-4857-A035-74F7AB9A1C76 Q35794798-6EFC4900-9727-4E6C-8BB3-B79BCFF5EC75 Q35806833-68AA6055-10E8-4406-AC6A-658C722D664E Q35887617-A951BD52-8889-445F-AB38-94D56EE7A3E9 Q35920353-5DEDF63E-3A48-4ED2-84BB-124B222273EB Q35976434-BED1C471-0272-44CD-9DE1-FF6ABD9B52C5 Q35989852-071D83F6-C678-4F3C-8B59-E522DB99D6EB Q36434366-B533636C-6956-46C8-A285-2DAE0BBC7A28 Q36809117-17AC344F-D94E-4CDC-BDAD-27480CBDDF52 Q36809137-72A9231B-B827-4142-8EB2-CEE20B7A5E44 Q36825737-07E49D14-DC05-48DE-9A95-54C69CDDEFA8 Q36849830-6A1EAB04-5B18-473F-BBB2-F6627B27AE7C Q36850638-BA7AC772-9700-46B3-8BD0-9A903ABE4707 Q36887966-44CCA863-7835-4C82-B57A-AD6ECBB87146 Q37130791-9C95AF1C-61CC-4248-BE84-0A97885DDEB8 Q37192707-0CE67E6F-D073-4C7F-94A8-3F61491A821D Q37252405-2DAA9841-CEE8-46AB-B815-C7D52A0FC271 Q37263960-ED9E416C-08AC-4335-BC42-3EA2345B2693 Q37689683-584ACBAC-2AD4-4E65-A823-7CD80D362ED7 Q37878375-9CAA9D32-3E5E-4BD6-8F40-CF5AA2A4D2DF Q38003082-CD55D9F1-780E-4CC6-93A2-83C9B58C3023 Q38066728-8F7F197B-EC99-4767-89D2-3BD59D25D135 Q38104685-4711E45B-EC8E-4CAC-9B66-A1B9D1ED77B6 Q38160248-C1E60317-BEF4-4336-8FA0-070C45913404 Q38325374-CC89BD59-FEF3-4D54-A859-4BE1ABFA383F Q38367830-124DBF74-D82C-41A3-BCD9-17461B73C67B Q40337543-F824EE0E-335A-43E8-B252-DA6AE5558729 Q41565524-8CCFECF6-9348-4945-8496-3E8F4CB2E435 Q45824896-EEDF5A70-78ED-4BD8-9A4C-9915262FB904 Q47301746-F65D8528-E80F-423E-97D9-8C2CE261822D Q47352260-A3305BAE-91A3-4050-99F7-4BC6D14BD01A Q47910467-242A0672-BA4B-44A3-9780-8818D03281F4 Q49377063-271ED347-5357-4972-AB37-FDD79CB2F0B7

P2860

The epidemiology of meningococcal disease and the impact of vaccines.

http://www.wikidata.org/entity/Q37706585

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The epidemiology of meningococcal disease and the impact of vaccines.

@en

The epidemiology of meningococcal disease and the impact of vaccines.

@nl

type

label

The epidemiology of meningococcal disease and the impact of vaccines.

@en

The epidemiology of meningococcal disease and the impact of vaccines.

@nl

prefLabel

The epidemiology of meningococcal disease and the impact of vaccines.

@en

The epidemiology of meningococcal disease and the impact of vaccines.

@nl

P1433

Q37706585-9F53FBA6-6637-4773-B80B-A604DF5550A3

P1476

Q37706585-FF2CA2C2-5E56-4FBC-AD03-6853E069FAF6

P2093

Q37706585-4574466A-B4CF-4420-A5F1-2D51ED45E971

Q37706585-A12DFD6C-3F80-4AD5-9587-EB4A7F0DCDA0

P2860

Q37706585-073B3A4F-C0B0-4E99-84FD-6B9118616B8D

Q37706585-0BAAE8BB-A776-42B4-B2CD-24987B4C5D13

Q37706585-0C0391EF-7EA0-43AA-9CAB-32B8215F1C67

Q37706585-0EE9F26C-FD58-4F73-9159-392B6B057946

Q37706585-127DF327-A84B-4C5C-B93D-EF07A9AC5A12

Q37706585-12C4E555-F2C4-47D3-981E-2DE2274D113E

Q37706585-1F7FDCD2-501F-48FA-ADB1-059765D13D97

Q37706585-206CC418-4506-4690-A728-FC738BB74B38

Q37706585-28390D4F-768B-4E25-B179-E12FF2B51275

Q37706585-2BB25DCE-A959-4E38-B679-516FE17C3A1D

P304

Q37706585-66054FE2-BF5E-4116-8FAD-9E514162001E

P31

Q37706585-ECDDCDA8-9401-4E08-839E-77863C904B2B

P356

Q37706585-0110268F-E998-4607-AA44-13CED6F2DB6C

P433

Q37706585-53924B26-7CD1-4CBB-9B1A-BC98ADEEE158

P478

Q37706585-0E92BD06-FC57-417F-A56E-1C4C7ED8A2E1

P577

Q37706585-98D68B33-DEE5-4494-BE98-574721DA6EE0

P698

Q37706585-029A7865-2CB7-4C99-9949-C95856691454

P921

Q37706585-F8990CCB-FFD1-41C1-A2DE-C2FB1E51B2BD

P356

P1433

Expert Review of Vaccines

P1476

The epidemiology of meningococcal disease and the impact of vaccines.

@en

P2093

Ameneh Khatami

http://www.w3.org/2001/XMLSchema#string

Andrew J Pollard

http://www.w3.org/2001/XMLSchema#string

P2860

Prospects for vaccine prevention of meningococcal infection

NadA, a novel vaccine candidate of Neisseria meningitidis

Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients

Invasive meningococcal disease epidemiology and control measures: a framework for evaluation

A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.

Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine

Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.

Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines.

Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents

Meningococcal vaccine in travelers.

P304

285-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.10.3

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20218857

http://www.w3.org/2001/XMLSchema#string

P921